Cargando…
Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings
Background: The follicle-stimulating hormone (FSH)-receptor (FSHR) has been reported to be an attractive target for antibody therapy in human cancer. However, divergent immunohistochemical (IHC) findings have been reported for FSHR expression in tumor tissues, which could be due to the specificity o...
Autores principales: | Möker, Nina, Peters, Solveig, Rauchenberger, Robert, Ghinea, Nicolae, Kunz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698838/ https://www.ncbi.nlm.nih.gov/pubmed/31548530 http://dx.doi.org/10.3390/antib6040015 |
Ejemplares similares
-
Correction: Moeker, N.; et al. Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings. Antibodies 2017, 6, 15
por: Möker, Nina, et al.
Publicado: (2018) -
In Vitro Impact of FSH Glycosylation Variants on FSH Receptor-stimulated Signal Transduction and Functional Selectivity
por: Zariñán, Teresa, et al.
Publicado: (2020) -
Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health
por: Ghinea, Nicolae
Publicado: (2021) -
Commentary: FSH and various forms of FSH receptors: distribution and their functions in gonads and extra-gonadal tissues
por: Kakar, Sham S., et al.
Publicado: (2021) -
Differential Regulation of Human and Mouse Myometrial Contractile Activity by FSH as a Function of FSH Receptor Density
por: Stilley, Julie A.W., et al.
Publicado: (2016)